Thomas E Schultz
Thomas E Schultz
Verified email at - Homepage
TitleCited byYear
The RP105/MD‐1 complex: molecular signaling mechanisms and pathophysiological implications
TE Schultz, A Blumenthal
Journal of leukocyte biology 101 (1), 183-192, 2017
Type I interferons in the pathogenesis of tuberculosis: molecular drivers and immunological consequences
ML Donovan, TE Schultz, TJ Duke, A Blumenthal
Frontiers in immunology 8, 1633, 2017
RP105 engages phosphatidylinositol 3-kinase p110δ to facilitate the trafficking and secretion of cytokines in macrophages during mycobacterial infection
CH Yu, M Micaroni, A Puyskens, TE Schultz, JC Yeo, AC Stanley, ...
The Journal of Immunology 195 (8), 3890-3900, 2015
The N‐terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105‐agonistic properties
TE Schultz, KH Wiesmüller, M Lucas, KM Dobos, AG Baxter, A Blumenthal
Journal of leukocyte biology 103 (2), 311-319, 2018
Characterisation of the molecular mechanisms of RP105-dependent macrophage activation
TE Schultz
Interference with Wnt pathway improves host control of Listeria monocytogenes in vivo
MD Gatica-Andrades, TTK Nguyen, TE Schultz, OJK Wyer, J Melo-Bolivar, ...
Immunology 143 (Suppl. 2), 112-112, 2014
The system can't perform the operation now. Try again later.
Articles 1–6